Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 19;10(8):439.
doi: 10.3390/v10080439.

Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak

David Brett-Major  1 , James Lawler  2
Affiliations
Review

Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak

David Brett-Major et al. Viruses. .

Abstract

After more than 28,000 Ebola virus disease cases and at least 11,000 deaths in West Africa during the 2014⁻2016 epidemic, the world remains without a licensed vaccine or therapeutic broadly available and demonstrated to alleviate suffering. This deficiency has been felt acutely in the two, short, following years with two Ebola virus outbreaks in the Democratic Republic of Congo (DRC), and a Marburg virus outbreak in Uganda. Despite billions of U.S. dollars invested in developing medical countermeasures for filoviruses in the antecedent decades, resulting in an array of preventative, diagnostic, and therapeutic products, none are available on commercial shelves. This paper explores why just-in-time research efforts in the field during the West Africa epidemic failed, as well as some recent initiatives to prevent similarly lost opportunities.

Keywords: emergency clinical management research; filovirus; global health; medical countermeasures review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. However, JVL founded JMEDICC, and both DMB and JVL since have provided it with technical advice.

References

    1. WHO . Situation Report: Ebola Virus Disease. WHO; Geneva, Switzerland: Jun 10, 2016. [(accessed on 4 August 2018)]. [cited 10 July 2018] Available online: http://apps.who.int/iris/bitstream/handle/10665/208883/ebolasitrep_10Jun....
    1. WHO . Ebola Virus Disease: Frequently Asked Questions on Compassionate Use of Investigational Vaccine for the Ebola Virus Disease Outbreak in Democratic Republic of the Congo. WHO; Geneva, Switzerland: May 23, 2018. [(accessed on 4 August 2018)]. [cited 10 July 2018] Available online: http://www.who.int/ebola/drc-2018/faq-vaccine/en/
    1. Joellenbeck L.M., Durch J.S., Benet L.Z. Giving Full Measure to Countermeasures: Addressing Problems in the DoD Program to Develop Medical Countermeasures against Biological Warfare Agents. Institute of Medicine and National Research Council of the National Academies; Washington, DC, USA: 2004. - PubMed
    1. Jones S.M., Feldmann H., Ströher U., Geisbert J.B., Fernando L., Grolla A., Klenk H.D., Sullivan N.J., Volchkov V.E., Fritz E.A., et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 2005;11:786–790. doi: 10.1038/nm1258. - DOI - PubMed
    1. The PREVAIL II Writing Group A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N. Engl. J. Med. 2016;375:1448–1456. doi: 10.1056/NEJMoa1604330. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources